Kyowa Kirin is a Japan-based global speciality pharmaceutical company that uses its deep expertise in antibody engineering and a passion for innovative drug discovery to target new disease pathways. They’ve delivered breakthrough medicines in oncology, nephrology, central nervous system and immunology. They are seeking to identify next‑generation biologics and small molecule drugs within the autoimmune and inflammation therapeutic areas.
Approaches of Interest
- Early-stage drug discovery and preclinical research to identify and advance next-generation biologics...